Connect with us

Health

WHO Urges Continued Funding for PEPFAR as US Freezes Foreign Aid

Published

on

The World Health Organization (WHO) has called for continued funding of global HIV programmes following the recent decision by US President Donald Trump to freeze foreign aid, a move that threatens treatment and testing for millions worldwide.

The funding suspension puts at risk access to HIV diagnostics, medicines, and treatment in low- and middle-income countries, according to WHO officials. The organisation warned that halting these programmes could lead to severe health consequences, particularly in regions heavily impacted by HIV/AIDS.

Dire Consequences of Funding Cuts

“A funding halt for HIV programmes can put people living with HIV at immediate increased risk of illness and death and undermine efforts to prevent transmission in communities and countries,” the WHO said in a statement.

Health officials fear that an extended pause on foreign assistance could undo decades of progress in the fight against HIV/AIDS, potentially returning the world to conditions seen in the 1980s and 1990s when millions died annually due to lack of treatment.

As of 2023, nearly 39.9 million people worldwide were living with HIV, with two-thirds residing in sub-Saharan Africa. Despite a significant reduction in AIDS-related deaths—from 2.1 million in 2004 to 630,000 in 2023—the disease remains a leading global health crisis.

Impact on PEPFAR and Global HIV Efforts

The most affected programme by the funding freeze is the President’s Emergency Plan for AIDS Relief (PEPFAR), which has been instrumental in saving more than 26 million lives since its launch in 2003 under then-President George W. Bush.

In 2024, PEPFAR provided antiviral HIV treatment to 20.6 million people across 55 countries. The programme also initiated 2.5 million individuals on pre-exposure prophylaxis (PrEP), a preventive measure against HIV infection, and facilitated testing for 83.8 million people.

See also  Obesity Linked to Poorer Outcomes in Childhood Cancer Patients, Study Finds

Beyond direct patient care, PEPFAR supports 342,000 health workers worldwide whose jobs are now in jeopardy due to the funding suspension. The freeze also affects additional US-backed foreign aid initiatives that collectively provide HIV treatment to 30 million people.

US Pullback from Global Health Leadership

President Trump’s decision to freeze foreign aid for health initiatives marks another step in scaling back US global health commitments. In addition to pausing PEPFAR funding, he has initiated the process of withdrawing the US from the WHO and reinstated the Mexico City Policy, which restricts US funding to foreign organisations that provide abortion-related services or information.

Trump has cited dissatisfaction with the WHO’s handling of the COVID-19 pandemic and concerns over the disproportionate US financial contributions to the organisation as reasons for these decisions.

Calls for Exemptions and Humanitarian Waivers

WHO officials have been working with nations benefiting from PEPFAR to develop long-term strategies for reducing dependency on US aid by 2030. However, the abrupt funding halt threatens to derail these efforts, putting millions of lives at risk, according to the organisation.

The WHO is advocating for exemptions to allow the continued delivery of essential HIV treatment and care. US Secretary of State Marco Rubio has reportedly granted a humanitarian waiver to maintain critical health services impacted by the freeze. According to The Washington Post, the waiver covers “core lifesaving medicine, medical services, food, shelter, and subsistence assistance.”

However, it remains unclear whether the exemption will apply to PEPFAR, leaving the future of millions of HIV patients in uncertainty. Global health advocates continue to urge the US government to reinstate funding for these essential programmes to prevent a major health crisis.

Health

Early Flu Wave Hits Europe as Experts Offer Tips to Ease Symptoms

Published

on

Most people catch a cold in winter, battling fatigue, runny noses, sneezes, coughs, and congestion. This season, an unusually early flu wave has affected millions across Europe, prompting health authorities to offer guidance on managing symptoms.

Typically, influenza season runs from mid-November to late May. However, figures from the European Centre for Disease Prevention and Control (ECDC) indicate that cases in 2025 surged three to four weeks earlier than in the previous two seasons. The agency reports that flu circulation remains high, though it has recently peaked in most regions.

While there are no specific cures for the flu and the common cold, some simple measures can help manage symptoms and improve comfort. Experts recommend a combination of hydration, rest, and symptom relief to support recovery.

Drinking enough fluids is particularly important. Water, broths, and warm beverages with honey, lemon, or ginger can help prevent dehydration, loosen mucus, and soothe irritated airways. Health authorities caution against alcohol, coffee, and other caffeinated drinks, which can act as diuretics and worsen congestion and sore throats.

Gargling with warm salt water is another simple measure to ease throat pain and reduce inflammation. Mixing one teaspoon of salt in a cup of warm water and using it several times a day can provide relief and help clear mucus.

Rest is essential for recovery. Adults are advised to sleep seven to nine hours a night, and to take naps as needed to allow the immune system to combat the virus. Light exercise such as short walks or yoga may be suitable for mild symptoms, but physical activity should be avoided if fever is present or chest symptoms worsen, to prevent complications.

See also  Human Metapneumovirus Outbreak in China Sparks Global Attention

Maintaining moisture in the environment can also alleviate symptoms. Dry air worsens congestion and sore throats, while humidified air hydrates airways and helps clear mucus. Higher humidity can also reduce how long some respiratory viruses survive in the air.

Medicines can relieve symptoms but do not cure viral infections. Decongestants, such as saline sprays or drops, can ease nasal congestion. Painkillers, including ibuprofen, may reduce fever and discomfort in adults. Antibiotics are not effective against colds or flu and should be avoided to prevent antibiotic resistance.

Health authorities emphasize that these measures, combined with good hygiene and vaccination where appropriate, are key to limiting the impact of seasonal viruses. The ECDC notes that most healthy adults recover from flu within about a week, while a common cold may last up to two weeks.

With the early flu wave affecting millions across Europe, simple steps such as staying hydrated, resting, and taking appropriate symptom relief can help patients recover safely and reduce strain on healthcare services.

Continue Reading

Health

Climate Change Drives Respiratory Illness, Push for Low-Carbon Inhalers Grows

Published

on

As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon inhalers to cut emissions from care and protect patients.

For millions of people worldwide, climate change is already affecting breathing. Rising air pollution, longer pollen seasons, and smoke from wildfires are contributing to asthma attacks, lung damage, and other chronic respiratory illnesses. At the same time, the health systems treating these conditions are themselves contributing to greenhouse gas emissions.

Experts note that over 90 percent of the global population breathe air with particulate levels above World Health Organization recommendations. Climate extremes and poor air quality are increasing the frequency and severity of respiratory diseases, from exacerbations to disease onset. Therese Laperre, head of the respiratory department at University Hospital Antwerp, said changes in particulate matter can trigger emergency visits for asthma and chronic pulmonary diseases days later. A European Environment Agency study estimated that more than a third of chronic respiratory disease deaths in Europe are linked to environmental factors such as pollution, extreme temperatures, wildfire smoke, and allergenic pollen.

Worldwide, an estimated 400 to 500 million adults live with COPD, and over 250 million have asthma. Health care responses come with their own climate cost. Health Care Without Harm estimates global health services generate about five percent of worldwide greenhouse gas emissions, which could rise to six gigatons annually by 2050 if unchecked, equivalent to more than a billion cars on the road. Hospitals, particularly intensive care units, are among the most carbon-intensive, due to high energy use, equipment, and single-use materials.

See also  Switzerland Reports First Case of Contagious New Mpox Strain as Outbreak Spreads Across Europe

Respiratory specialists emphasize that early disease control benefits both patients and the environment. Philippe Tieghem from the French respiratory association Sante Respiratoire said early diagnosis allows for better patient care while reducing emissions.

Inhalers, commonly used to treat asthma and COPD, illustrate the challenge. Traditional pressurised metered-dose inhalers (pMDIs) use hydrofluorocarbon propellants, which contribute 16–17 million tonnes of CO₂-equivalent emissions globally each year. The UK’s National Health Service estimates these inhalers account for around three percent of its carbon footprint.

Pharmaceutical companies are developing greener alternatives. AstraZeneca’s reformulated COPD inhaler uses a new propellant, HFO‑1234ze(E), cutting its global warming potential by roughly 99.9 percent compared with older devices. The company has pledged to reduce its emissions by 98 percent by 2026, starting with inhalers. Pfizer and Johnson & Johnson have committed to net-zero targets by 2040 and 2045, respectively.

Pablo Panella, senior vice-president for respiratory diseases at AstraZeneca, told Euronews Health that early detection, diagnosis, and treatment keep patients controlled in the community, reducing hospital admissions and the high-carbon interventions that come with them. Panella also stressed the importance of regulation that supports innovation, allowing low-carbon technologies to reach patients more quickly.

Better disease control, combined with environmentally conscious products, is creating the concept of the “green patient”: someone whose chronic condition is managed well enough to avoid repeated flare-ups, hospital stays, and carbon-intensive treatments.

Continue Reading

Health

Experts Offer Tips to Beat Winter Blues on “Blue Monday”

Published

on

Monday, 19 January, is often called Blue Monday, reportedly the “saddest day of the year.” The term was coined in 2005 by UK psychologist Cliff Arnall for a travel company, Sky Travel, as a way to promote winter holidays. Arnall’s formula combined weather data, debt levels, time since Christmas, motivation, and the status of New Year’s resolutions to identify the third Monday of January as particularly gloomy. However, experts say there is no scientific evidence supporting the idea that this day is inherently sadder than any other.

While Blue Monday itself is not backed by research, the winter months can be challenging for many people. Shorter daylight hours, colder temperatures, and reduced outdoor activity contribute to what is often referred to as the “winter blues.” Seasonal Affective Disorder (SAD), a type of depression linked to seasonal changes, is most common during late autumn and winter. Symptoms include low mood, fatigue, difficulty concentrating, disrupted sleep, and a loss of interest in usual activities. Experts link SAD to reduced sunlight, which can affect serotonin and melatonin, the body’s natural chemicals that regulate mood and energy.

Happiness expert Stephanie Davies says overcoming the winter slump does not require drastic changes, but small, intentional steps that support mental well-being. Regular exercise, exposure to sunlight, good sleep, and social connection can all help counter the seasonal dip in mood.

Exercise, even for 20 minutes a day, can release endorphins and improve motivation. Outdoor activity is particularly beneficial, as daylight exposure helps regulate sleep patterns and boost energy. Research has shown that physical activity can be as effective as therapy or medication in easing symptoms of depression, including fatigue and sadness.

See also  Traditional East African Diet Found to Lower Inflammation and Boost Health, Study Finds

Sunlight exposure is also critical. Natural light helps adjust the body’s internal clock and increases serotonin levels, improving energy and alertness. Experts recommend keeping living spaces bright and spending time outdoors when possible. Light therapy is another effective treatment for those suffering from SAD.

Maintaining a regular sleep schedule is equally important. Adults generally need seven to nine hours of sleep a night, and maintaining consistent sleep patterns helps regulate circadian rhythms. Excessive napping or irregular sleep can worsen low energy and mood.

Social connection provides another important benefit. Reduced daylight and colder weather often lead people to stay home, increasing feelings of isolation. Whether through face-to-face interaction, phone calls, or messages, maintaining contact with friends and family can help reduce loneliness and improve overall well-being.

While Blue Monday may be more of a media concept than a scientific fact, experts agree that proactive steps to maintain activity, light exposure, sleep, and social contact can make the winter months more manageable and support both mental and physical health.

Continue Reading

Trending